Therefore, this study highlights SH3GL1 as a novel regulator of ferroptosis in DLBCL, suggesting that targeting SH3GL1 may be a promising strategy to prevent DLCBL progression and overcome the resistance to traditional cancer treatments (Figure 7F). This evidence concerns the gene SH3GL1 and cancer.